blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2233480

EP2233480 - Chemical compounds [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.04.2014
Database last updated on 26.06.2024
Most recent event   Tooltip04.09.2015Lapse of the patent in a contracting state
New state(s): MT		published on 07.10.2015  [2015/41]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2010/39]
Inventor(s)01 / Mccoull, William
AstraZeneca R&D Alderely
3S105, Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
02 / Scott, James Stewart
AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TGch / GB
03 / Whittamore, Paul Robert Owen
AstraZeneca R&D Alderley
Mereside, Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
04 / Packer, Martin
AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
 [2013/22]
Former [2010/39]01 / Mccoull, William
AstraZeneca R&D Alderely 3S105, Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
02 / Scott, James Stewart
AstraZeneca R&D Alderley Alderley Park
Macclesfield, Cheshire SK10 4TGch / GB
03 / Whittamore, Paul Robert Owen
AstraZeneca R&D Alderley Mereside, Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
04 / Packer, Martin
AstraZeneca R&D Alderley Alderley Park
Macclesfield, Cheshire SK10 4TG / GB
Application number, filing date10163730.431.10.2007
[2010/39]
Priority number, dateUS20060864303P03.11.2006         Original published format: US 864303 P
US20060864247P03.11.2006         Original published format: US 864247 P
[2010/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2233480
Date:29.09.2010
Language:EN
[2010/39]
Type: B1 Patent specification 
No.:EP2233480
Date:29.05.2013
Language:EN
[2013/22]
Search report(s)(Supplementary) European search report - dispatched on:EP25.08.2010
ClassificationIPC:C07D401/04, C07D401/12, C07D401/14, C07D413/04, A61K31/44, A61K31/444, A61K31/4439
[2010/39]
CPC:
C07D401/04 (EP,US); C07D213/82 (KR); A61K31/4402 (KR);
A61K31/444 (KR); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07D401/14 (KR); C07D413/04 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/39]
Extension statesAL29.03.2011
BA29.03.2011
HR29.03.2011
MK29.03.2011
RS29.03.2011
TitleGerman:Chemische Verbindungen[2010/39]
English:Chemical compounds[2010/39]
French:Composés chimiques[2010/39]
Examination procedure25.05.2010Examination requested  [2010/39]
08.12.2010Despatch of a communication from the examining division (Time limit: M04)
24.05.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
26.07.2011Reply to a communication from the examining division
29.09.2011Despatch of a communication from the examining division (Time limit: M06)
19.03.2012Reply to a communication from the examining division
07.01.2013Communication of intention to grant the patent
12.04.2013Fee for grant paid
12.04.2013Fee for publishing/printing paid
Parent application(s)   TooltipEP07824375.5  / EP2086939
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070824375) is  04.08.2009
Opposition(s)03.03.2014No opposition filed within time limit [2014/19]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
26.07.2011Request for further processing filed
26.07.2011Full payment received (date of receipt of payment)
Request granted
04.08.2011Decision despatched
Fees paidRenewal fee
27.09.2010Renewal fee patent year 03
02.11.2010Renewal fee patent year 04
31.10.2011Renewal fee patent year 05
31.10.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.10.2007
AT29.05.2013
BE29.05.2013
CY29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
MT29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
IE31.10.2013
LU31.10.2013
[2015/41]
Former [2015/34]HU31.10.2007
AT29.05.2013
BE29.05.2013
CY29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
IE31.10.2013
LU31.10.2013
Former [2015/30]AT29.05.2013
BE29.05.2013
CY29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
IE31.10.2013
Former [2014/48]AT29.05.2013
BE29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
IE31.10.2013
Former [2014/25]AT29.05.2013
BE29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
MC29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
Former [2014/11]AT29.05.2013
BE29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
RO29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
Former [2014/10]AT29.05.2013
BE29.05.2013
CZ29.05.2013
DK29.05.2013
EE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
SI29.05.2013
SK29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
Former [2014/09]AT29.05.2013
BE29.05.2013
DK29.05.2013
EE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
Former [2014/06]AT29.05.2013
BE29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
Former [2014/02]AT29.05.2013
FI29.05.2013
LT29.05.2013
LV29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
Former [2013/50]AT29.05.2013
FI29.05.2013
LT29.05.2013
PL29.05.2013
SI29.05.2013
BG29.08.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
Former [2013/49]AT29.05.2013
FI29.05.2013
LT29.05.2013
SI29.05.2013
GR30.08.2013
IS29.09.2013
PT30.09.2013
Former [2013/48]AT29.05.2013
LT29.05.2013
IS29.09.2013
PT30.09.2013
Former [2013/47]LT29.05.2013
PT30.09.2013
Documents cited:Search[A]WO2004065351  (NOVARTIS AG [CH], et al) [A] 1-16 * claims 1-38 *;
 [A]WO2004089896  (NOVO NORDISK AS [DK], et al) [A] 1-16 * claims 1-36 *;
 [E]WO2008012532  (ASTRAZENECA AB [SE], et al) [E] 1-16 * claims 1-14 *;
 [A]  - BARF T ET AL, "Recent progress in 11-[beta]-hydroxysteroid dehydrogenase type 1 (11-[beta]-HSD1) inhibitor development", DRUGS OF THE FUTURE, BARCELONA, ES, (20060301), vol. 31, no. 3, ISSN 0377-8282, pages 231 - 243, XP002424785 [A] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1358/dof.2006.031.03.884977
ExaminationUS2004133008
by applicantWO03086410
 WO2005080342
    - DALLMAN MF; STRACK AM; AKANA SF ET AL., FRONT NEUROENDOCRINOL, (1993), vol. 14, pages 303 - 347
    - BUJALSKA IJ ET AL., ENDOCRINOLOGY, (1999), vol. 140, pages 3188 - 3196
    - BJORNTORP P; ROSMOND R, INT. J. OBESITY, (2000), vol. 24, pages S80 - S85
    - SANDEEP TC; WALKER BR, TRENDS IN ENDOCRINOL & METAB., (2001), vol. 12, pages 446 - 453
    - WALKER BR ET AL., J. CLIN. ENDOCRINOL. METAB., (1995), vol. 80, pages 3155 - 3159
    - JESSOP DS ET AL., J. CLIN. ENDOCRINOL. METAB., (2001), vol. 86, pages 4109 - 4114
    - RASK E ET AL., J. CLIN. ENDOCRINOL. METAB., (2001), pages 1418 - 1421
    - BUJALSKA IJ ET AL., LANCET, (1997), vol. 349, pages 1210 - 1213
    - KOTELEVTSEV Y ET AL., PROC. NATL. ACAD. SCI USA, (1997), vol. 94, pages 14924 - 14929
    - MORTON NM ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 41293 - 41300
    - MASUZAKI H ET AL., SCIENCE, (2001), vol. 294, pages 2166 - 2170
    - WHORWOOD CB ET AL., J. CLIN. ENDOCRINOL. METAB., (2001), vol. 86, pages 2296 - 2308
    - DAVANI B ET AL., J. BIOL. CHEM., (2000), vol. 275, pages 34841 - 34844
    - COOPER MS ET AL., BONE, (2000), vol. 27, pages 375 - 381
    - RAUZ S ET AL., INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, (2001), vol. 42, pages 2037 - 2042
    - THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 26, no. 25, pages 16653 - 16658
    - PROCEEDINGS OF NATIONAL ACADEMY OF SCIENCES, (2001), vol. 98, no. 8, pages 4717 - 4721
    - J. EXPERIMENTAL MEDICINE, (2005), vol. 202, no. 4, pages 517 - 527
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.